Cuba vs Mexico: Access to anti-retroviral drugs, male
Cuba
66.0%
in 2024
Mexico
67.0%
in 2024
Cuba rank
80th
Mexico rank
78th
Access to anti-retroviral drugs, male over time
- Cuba
- Mexico
How they compare
Mexico currently reports 67.0% against 66.0% in Cuba, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Mexico ahead.
Cuba ranks 80th and Mexico ranks 78th of 141 countries.
Across the 3 decades both report, Cuba averaged higher in 2 and Mexico in 1.
Head to head by decade
| Decade | Cuba | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.1% | 20.0% | 5.9% | Mexico |
| 2010s | 46.4% | 40.3% | 6.1% | Cuba |
| 2020s | 66.2% | 63.2% | 3.0% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cuba or Mexico?
- Mexico, at 67.0% against 66.0% in Cuba as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cuba and Mexico?
- 1.0%, with Mexico ahead.
- How many years of comparable data are there for Cuba and Mexico?
- 25 years are reported by both, from 2000 to 2024.
- How do Cuba and Mexico rank globally for access to anti-retroviral drugs, male?
- Cuba ranks 80th and Mexico ranks 78th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.